NERON Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 8

NERON General Information

Description

Developer of gut microbiome therapeutics designed to support mental and physical health through the gut-brain axis. The company offers proprietary gut microbiome cocktails formulated through microbiome profiling, strain selection and gut-brain axis research, enabling individuals seeking relief from anxiety, stress and broader health challenges to support both mental resilience and overall physiological well-being with science-based interventions.

Contact Information

Website
www.neron.jp
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1-29-3 Higashi, Shibuya-City
  • Shibuya Bridge Building B, Room 1c
  • Tokyo, 150-0001
  • Japan
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 1-29-3 Higashi, Shibuya-City
  • Shibuya Bridge Building B, Room 1c
  • Tokyo, 150-0001
  • Japan

NERON Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NERON Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Accelerator/Incubator 01-Jul-2026 Completed Generating Revenue
7. Seed Round 28-Mar-2025 Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2025 Completed Startup
5. Accelerator/Incubator Completed Startup
4. Accelerator/Incubator 12-Dec-2023 Completed Startup
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator Completed Startup
To view NERON’s complete valuation and funding history, request access »

NERON Patents

NERON Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025254155-A1 Serotonin secretion-promoting composition, food or drink, cosmetic, and medicine containing said composition, and methods for producing same Pending 05-Jun-2024

NERON Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NERON Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
01Booster Accelerator/Incubator
Mitsubishi Estate Real Estate
Glocalink Venture Capital Minority
Tech Planter Accelerator/Incubator
FASTAR Accelerator/Incubator
You’re viewing 5 of 8 investors. Get the full list »

NERON FAQs

  • When was NERON founded?

    NERON was founded in 2022.

  • Where is NERON headquartered?

    NERON is headquartered in Tokyo, Japan.

  • What is the size of NERON?

    NERON has 3 total employees.

  • What industry is NERON in?

    NERON’s primary industry is Biotechnology.

  • Is NERON a private or public company?

    NERON is a Private company.

  • What is NERON’s current revenue?

    The current revenue for NERON is .

  • How much funding has NERON raised over time?

    NERON has raised $134K.

  • Who are NERON’s investors?

    01Booster, Mitsubishi Estate, Glocalink, Tech Planter, and FASTAR are 5 of 8 investors who have invested in NERON.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process